Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aleglitazar add-on to Sulfonylurea +/- Metformin in T2D
NCT01691989Phase 3Completed
- Sponsor
- Roche
- Start
- Dec 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of aleglitazar in type 2 diabetes mellitus (T2DM), sponsored by Roche. Started Dec 2012; status: completed.
02
Drugs
aleglitazar
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01691989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01691989.